You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of Novel Fast GPU Monte Carlo and Active Photonics Simulation Software for Predicting PDT Efficacy
SBC: SIMPHOTEK, INC. Topic: 102DESCRIPTION provided by applicant Photodynamic therapy PDT provides for standalone or intraoperative cancer treatment PDT provides a means to treat superficial and or residual disease while minimizing damage to underlying tissues and does not exhibit cumulative cell toxicities distinguishing it from radiation therapy As compared to radiotherapy treatment planning in PDT is often approa ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Percutaneous DLC for Total Cavo pulmonary Assistance
SBC: W-Z BIOTECH LLC Topic: NHLBIDESCRIPTION provided by applicant The Fontan procedure or total cavopulmonary connection TCPC is a standard palliative surgery for patients with complex single ventricle congenital heart anomalies TCPC connects the inferior and superior vena cava IVC and SVC directly to the right pulmonary artery bypassing the heart The single ventricle is then reserved for pumping oxygenated blood to th ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of protein therapeutic for acute kidney injury
SBC: TRIM-EDICINE INC Topic: 400Project Summary This direct Phase II SBIR proposal focuses on the development of recombinant human MGrhMGa novel tissue repair proteinas a therapeutic candidate targeting injury of renal epithelium to protect against acute kidney injuryAKIAKI is commonly encountered in the hospital and outpatient settings and is associated with a high rate of mortalityCurrentlythere is no effective means for preve ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System
SBC: ABT Molecular Imaging Topic: 102DESCRIPTION provided by applicant Worldwide a person dies from cancer every seconds Positron emission tomography PET is an effective tool that is critical in diagnosing cancer and monitoring treatment efficacy PET imaging relies on use of short lived radioisotopes Commercial distribution of the most commonly used radio tracer F FDG has resulted in patient population coverage in ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Exploiting Natural Products-Based Therapeutics for Aflatoxin Mitigation
SBC: CFD RESEARCH CORPORATION Topic: CBD152003Aflatoxins are a paradigm among fungal produced mycotoxins that are present in food supplies and are strongly associated with increased risk forthe development of hepatocellular carcinoma. Currently, there are no known countermeasures that can selectively mitigate aflatoxin toxicity andthe available options are only symptomatic treatments. To meet this challenge, we propose to harness the microbio ...
SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense -
Feasibility of Mobile Augmented Reality Intervention Preventing Youth Alcohol Use
SBC: REAL PREVENTION LLC Topic: 10DESCRIPTION provided by applicant The overall goal of the proposed project is to leverage a widely disseminated elementary alcohol and other drug use prevention curriculum to create a mobile version that enhances engagement and promotes transfer of learning to out of class decisions The project represents a collaboration among three businesses dedicated to innovative use of technology for alco ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
SBC: DISCOVERYBIOMED, INC. Topic: 200DESCRIPTION provided by applicant DiscoveryBioMed Inc DBM Inc or DBM specializes in normal and diseased human cell platform engineering DBM has assembled a consortium of experts whereby collectively we seek Fast Track SBIR funding to establish and offer a Product Line Menu of normal and ADPKD human cell platforms for the academic and industry marketplaces Existing and interested DBM ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Glycosaminoglycan Interacting Small Molecule GISMO as Parkinson s Therapeutic
SBC: GISMO THERAPEUTICS INC. Topic: 106Glycosaminoglycan Interacting Small Molecule GISMO As Parkinsonandapos s Therapeutics ABSTRACT Current approved drugs for Parkinsonandapos s Disease PD treat the symptoms of the disease but do not stop disease progression This project is focused on developing a new disease modifying PD therapeutic with a novel mode of action that is expected to block disease progression Recent data indicate ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
High definition pressure mapping and electromyography for female pelvic floor guided therapy
SBC: ADVANCED TACTILE IMAGING INC Topic: NDESCRIPTION provided by applicant Urinary incontinence UI and overactive bladder OAB are highly prevalent in women and their prevalence is increased with the age In a representative United States survey UI was reported to affect from to of women The OAB prevalence estimates vary considerably among studies ranging from to These conditions are socially embarrassing causin ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF ESTABLISHMENT OF CANCER CELL LINES FOR ADVANCING OVARIAN CANCER HEALTH DISPARITY RESEARCH
SBC: Tatva Biosciences, LLC Topic: NCIOvarian cancer OC disproportionately affects the women of African American AA background at all stages of the disease from presentation through treatment Most upsetting fact is that AA patients have greater mortality and their survival rates are continuously decreasing as compared to Caucasian American CA Success in understanding and characterizing the involved mechanisms in existing rac ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health